Carotid Revascularization Versus 治疗缺血性中风的医疗管理与ipsilateral Carotid Web:一个系统的审查和元分析
Farhan Khan1, Choudhary A Rehman2, Lauren Fletcher3
1Department of Neurology, Brown University, Providence, RI, USA.
Annals of neurology
|June 12, 2025
概括
与单独的医疗管理相比,动脉再血管化显著降低了患有动脉网络的患者的复发性缺血性中风风险. 关节内关节切除术和支架都显示出类似的有效性,尽管由于研究的局限性,研究结果需要谨慎解释.
科学领域:
- 神经学 神经学
- 血管外科 血管外科
- 脑卒中医学 脑卒中医学
背景情况:
- 动脉网络是缺血性中风的一个未被认可的原因.
- 患有动脉网络的患者面临复发性缺血事件的高风险.
- 对于中风患者的最佳治疗策略仍然不确定.
研究的目的:
- 系统地审查和分析医疗管理与心脏动脉复血管化对患有缺血性中风和双侧心脏动脉网患者的有效性.
- 为了比较不同管理策略之间的复发性中风率.
主要方法:
- 观察性研究的系统审查和元分析.
- 搜索了Embase,Scopus,MEDLINE,Web of Science和CINAHL数据库中的数据库.
- 包括比较医疗管理 (抗血小板/抗凝药) 与大脑动脉复血管化 (内膜切除/支架) 的研究.
- 使用随机效应建模来计算风险比率和95%置信区间.
主要成果:
- 包括17项研究 (16项已发表,1项机构研究).
- 仅仅医疗管理就导致了32%的患者出现复发性缺血性中风.
- 冠状动脉再血管化显著降低了复发性缺血性中风的风险 (RR 0.11,95% CI 0.06-0.28).
- Carotid Endarterectomy 和支架在减少中风复发方面表现出相似的有效性.
结论:
- 动脉复血管化与患有动脉网络的患者中复发性缺血性中风的比率较低有关.
- 在动脉内关节切除术和动脉支架之间没有观察到有效性的显著差异.
- 由于小,异质的队列和前性比较研究的需要,研究结果应谨慎解释.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Aneurysm III: Interprofessional Care
478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478


